“…[19][20][21] In addition, concerns among the public, especially in LMICs, about accessing RT-PCR testing facilities, especially if this involves interacting with patients with COVID-19, potentially travelling long distances to access testing sites with associated time and cost implications and conflicts with work schedules, as well as a lack of privacy. [22][23][24] The concept of self-testing with rapid, lateral flow, SARS-CoV-2 antigen detection tests (RADT) helps to address these concerns, 13,19,[22][23][24] building on existing strategies for patients with diabetes as well as those with HIV, hepatitis C, malaria, and syphilis, testing themselves at home. 13,19,[25][26][27][28][29][30] The benefits of self-testing at home included greater uptake, ability to test at scale, efficiency with for instance no additional staff and personal protective equipment (PPE) involved, increased privacy reducing the potential for possible stigma, lack of contact with possible patients with COVID-19 in healthcare facilities as well as convenience.…”